Season 2 Episode 4: Potential to Use IL-2 for Celiac Diagnosis

$0.00

<< Return to Courses

In this episode of Raising Celiac, we dive into the evolving science of celiac disease diagnosis with Dr. Jason Tye-Din, a leading gastroenterologist and researcher from Melbourne, Australia. Join us as we explore the role of interleukin-2 (IL-2) as a groundbreaking biomarker, offering a potential path to less invasive and more accurate diagnostic methods. We’ll also hear Jonah’s story—a decade-long journey of living gluten-free without a formal diagnosis—and discuss how innovations like IL-2 testing could transform the diagnostic process for people like him.

 

Category:

Description

In this episode of Raising Celiac, we dive into the evolving science of celiac disease diagnosis with Dr. Jason Tye-Din, a leading gastroenterologist and researcher from Melbourne, Australia. Join us as we explore the role of interleukin-2 (IL-2) as a groundbreaking biomarker, offering a potential path to less invasive and more accurate diagnostic methods. We’ll also hear Jonah’s story—a decade-long journey of living gluten-free without a formal diagnosis—and discuss how innovations like IL-2 testing could transform the diagnostic process for people like him.

 

Learning Objectives:  At the conclusion of this educational program, learners will be able to:

  1. Explain how interleukin-2 (IL-2) functions as a biomarker and its potential to improve the accuracy and reduce the invasiveness of celiac disease diagnostic methods.
  2. Understand how IL-2 might address current gaps in traditional diagnostic pathways for celiac disease.
  3. Demonstrate how IL-2 could improve diagnostic outcomes for individuals living with celiac disease symptoms but without formal diagnosis

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Social Worker

As a Jointly Accredited Organization, Boston Children’s Hospital is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Boston Children’s Hospital maintains responsibility for this course. Social workers completing this course receive 0.75 ACE CE continuing education credits.

Nurse

Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Dietician

Boston Children’s Hospital designates this activity for 0.75 contact hours for dieticians. Dieticians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy 

Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Vanessa Weisbrod: None

Janis Arnold, MSW, LICSW: None

Jason Tye-Din MBBS, FRACP, PhD: Independent contractor (including contracted research), Novoviah Pharmaceuticals; Consultant, Chugai Pharmaceuticals; Consultant, Dr Falk; Consultant, Janssen; Consultant, TEVA

Additional information

Credit Type

, , ,

Duration

Format

Topic

Expiration Date

Release Date

Faculty

Vanessa Weisbrod headshotVanessa Weisbrod
Director, Celiac Disease Program






Janis Arnold headshot

Janis Arnold, MSW, LICSW

Clinical Social Worker, Division of Gastroenterology, Hepatology, and Nutrition






Jason-Tye-Din-HeadshotJason Tye-Din MBBS, FRACP, PhD

The Walter and Eliza Hall Institute of Medical Research